Nureca Limited

NSE:NURECA.NS

287.15 (INR) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 264.63311.89202.69169.7223.74313.53212.31212.26277.88367.81255.28410.49480.77469.41,194.82318.4594.69919.28302.17329.6
Cost of Revenue 165.31202.76164.55111.81158.79191.34144.21143.21167.13274.16170.81258.79292.53280.49494.43164.48328.34382.1696.74224.04
Gross Profit 99.32109.1338.1457.8964.95122.1968.169.05110.7593.6584.47151.7188.24188.91700.39153.92266.35537.12205.43105.56
Gross Profit Ratio 0.3750.350.1880.3410.290.390.3210.3250.3990.2550.3310.370.3920.4020.5860.4830.4480.5840.680.32
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 000-9.5900039.7300037.1700041.8818.5356.315.370
Selling & Marketing Expenses 00040.2700035.98000117.3800047.9447.9417.62.530
SG&A 096.4268.3930.6874.7177.6927.8975.7180.0492.742.79154.5520.3222.91204.3189.8266.47523.917.98.57
Other Expenses 99.32057.94-12.5959.0131.9926.7321.4818.9618.911.71-57.3317.3621.121.39-14.47.16.641.640
Operating Expenses 99.3296.4268.39108.23113.41114.22102.96109.22125.92148.92147.83177.22141.27131.69231.0199.97165.08176.0976.4669.44
Operating Income 00-30.25-62.9310.5539.96-34.86-18.693.79-36.37-63.36-33.346.9757.22469.3854.5685.27368.19128.9735.65
Operating Income Ratio 00-0.149-0.3710.0470.127-0.164-0.0880.014-0.099-0.248-0.0810.0980.1220.3930.1710.1430.4010.4270.108
Total Other Income Expenses Net -32.52-0.75-18.51-41.46-22.71-52.4225.57-12.68-68.18-1.0210.366.4716.2319.8619.2-1.96-16.38-1.58-1.97-3.37
Income Before Tax -32.52-0.7526.19-64.729.4539.12-9.29-19.732.7-37.39-53-19.0563.277.08488.5851.9984.89359.4512732.28
Income Before Tax Ratio -0.123-0.0020.129-0.3810.0420.125-0.044-0.0930.01-0.102-0.208-0.0460.1310.1640.4090.1630.1430.3910.420.098
Income Tax Expense -4.514.079.57-23.267.810.18-2.22-4.43-0.31-8.47-11.71-5.1115.8622.74126.6213.0821.8692.1232.538.46
Net Income -28.01-4.8216.62-41.461.6528.94-7.07-15.33.01-28.92-41.29-13.9447.3454.34361.9638.9163.03267.3394.4723.82
Net Income Ratio -0.106-0.0150.082-0.2440.0070.092-0.033-0.0720.011-0.079-0.162-0.0340.0980.1160.3030.1220.1060.2910.3130.072
EPS -2.8-0.481.66-4.150.172.89-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EPS Diluted -2.8-0.481.66-4.150.172.89-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EBITDA -25.378.1434.25-56.9316.4645.84-2.3-13.089.8-30.18-45.58-10.2868.5681.44492.3256.4987.03361.55131.5335.843
EBITDA Ratio -0.0960.026-0.117-0.3350.0740.146-0.011-0.0620.035-0.082-0.179-0.0320.1430.1730.4120.1730.1460.4010.4350.109